XML 19 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statement of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at the beginning of the period at Dec. 31, 2014 $ 1 $ 5,201 $ (4,088)   $ 1,114
Balance at the beginning of the period (in shares) at Dec. 31, 2014 6,191        
Increase (decrease) in equity          
Pre-merger equity issuance $ 9 86,991     87,000
Pre-merger equity issuance (in shares) 89,489        
Equity issuance costs   (2,746)     (2,746)
Dividend   (1,040)     (1,040)
Net loss     (7,764)   (7,764)
Balance at the end of the period at Dec. 31, 2015 $ 10 88,406 (11,852)   76,564
Balance at the end of the period (in shares) at Dec. 31, 2015 95,680        
Increase (decrease) in equity          
Other comprehensive loss       $ (27) (27)
Net loss     (8,439)   (8,439)
Balance at the end of the period at Dec. 31, 2016 $ 10 88,406 (20,291) (27) $ 68,098
Balance at the end of the period (in shares) at Dec. 31, 2016 95,680       95,700
Increase (decrease) in equity          
Pre-merger equity issuance   20,100     $ 20,100
Pre-merger equity issuance (in shares) 2,810        
Reverse recapitalization $ 1 26,773     26,774
Reverse recapitalization (in shares) 6,759        
Issuance of common stock   10,000     10,000
Issuance of common stock (in shares) 1,026        
Equity issuance costs   (6,295)     (6,295)
Share-based compensation   19,754     19,754
Other comprehensive loss       (13) (13)
Net loss     (35,326)   (35,326)
Balance at the end of the period at Dec. 31, 2017 $ 11 $ 158,738 $ (55,617) $ (40) $ 103,092
Balance at the end of the period (in shares) at Dec. 31, 2017 106,275       106,300